Saint-Pierre & Miquelon: Young Researcher Studies Alzheimer’s at University of Montreal

Montréal is becoming a hub for cutting-edge research into neurodegenerative diseases and one local doctoral student is at the forefront of that effort. Flavie Detcheverry, originally from Saint-Pierre-et-Miquelon, is dedicating her work to understanding the complexities of brain aging and the progression of Alzheimer’s disease. Her research focuses on identifying subtle changes in the brain that occur with age and how these changes relate to the development of this devastating illness.

Detcheverry’s path to biomedical engineering wasn’t direct. After completing her baccalauréat scientifique with a specialization in mathematics in 2018, she moved from her island home to pursue a degree in cognitive neuroscience at the Université de Montréal. This foundational education sparked a passion for understanding the brain and the intricate link between brain activity and behavior. She graduated in 2021 with a specialization in clinical neuropsychology, setting the stage for her current research endeavors. The growing global burden of Alzheimer’s disease, affecting millions worldwide, underscores the urgency of this type of investigation.

From Neuroscience to Biomedical Engineering

Following her undergraduate studies, Detcheverry transitioned into the field of research, earning a master’s degree in biomedical engineering. This interdisciplinary field combines medical science with engineering principles, allowing for the development of innovative tools for analysis and imaging. In January 2023, she accelerated her academic journey, entering a doctoral program in biomedical engineering – a quick-track option reserved for students demonstrating exceptional aptitude and supported by their research supervisors. “The accelerated track is doing all the courses in one year instead of two. It’s competitive in this field,” Detcheverry explained, highlighting the demanding nature of her studies.

Currently, Detcheverry’s doctoral research is centered on healthy aging and the evolution of Alzheimer’s disease. She is particularly interested in the gradual changes that occur in the brain as we age, and how these changes might signal the onset of the disease. Her work at the MIND lab, under the supervision of Pr. Badhwar and Pr. Narayanan, specifically examines level changes of brain metabolites in both the brain and blood in healthy aging and Alzheimer’s disease, as detailed on the Vascular Training (VAST) Platform.

Analyzing Brain Structure and Chemistry

Detcheverry’s research employs advanced biomedical imaging techniques to analyze the structure and chemistry of the brain. She also investigates specific biomarkers present in the blood that may be linked to the development of Alzheimer’s. This dual approach – examining both the brain directly and analyzing peripheral biomarkers – aims to provide a more comprehensive understanding of the disease process. Her work, as documented on her ORCID profile, contributes to the broader effort to improve diagnostic tools and track the progression of Alzheimer’s.

The ultimate goal of this research is to better understand the earliest transformations associated with Alzheimer’s disease and to refine the tools used to monitor its progression. These advancements are crucial for developing more effective treatments and interventions. Detcheverry’s work is part of a larger, global effort to advance knowledge about this complex and challenging disease. She recently discussed her research on the program C’est vous qui l’dites.

Flavie Detcheverry’s profile on LinkedIn shows her experience at the CRIUGM – Centre de Recherche de l’Institut Universitaire de Gériatrie de Montréal (IUGM), further demonstrating her commitment to geriatric research.

As research into Alzheimer’s disease continues to evolve, the contributions of dedicated scientists like Flavie Detcheverry are vital. Future studies will likely focus on refining biomarker identification and developing personalized approaches to treatment and prevention. The ongoing investigation into the intricacies of brain aging promises to unlock new insights into this devastating disease and offer hope for improved outcomes for those affected.

What are your thoughts on the latest advancements in Alzheimer’s research? Share your comments below, and please share this article with your network to raise awareness about this important issue.

Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.